Who We Are

We are an international pharmaceutical group with 80 years of experience and a recent history of prestigious acquisitions and global expansion.

chi_siamo.png

Our manufacturing plants are located in Italy and we are present in over 40 countries in Europe, in the Medium and Far East, and in South America. We distribute directly or in a partnership with local realities, over 80 brands worldwide.

Our strength is the ability to create synergies that favour the access to products of guaranteed quality for patients and consumers all over the world.

Innovation, tradition and internationality

A long view into the future is constantly anchored to the values of our origin, the ones that have turned a family Italian company into a modern and international Pharmaceutical Group. Rigour and flexibility, innovation and tradition, are for us solid benchmarks that guarantee an excellent production. Our goal is to reach people with accessible and quality therapeutic solutions, in order to transfer the product’s value over time into treatments and well-being.

71

million turnover

40

countries

285

products in the world

84

brands

80

more years of exeperience

130

people employed directly

Laboratorio Farmaceutico SIT was founded.
1927
1973
Mercurocromo was acquired.
SIT provided itself with a sales force in Italy.
1987
1993
Eparema, Diube, Tauglicolo and Tauxolo were acquired.
Mercurocromo with merbromin was reformulated in SIT and relaunched as Neomercurocromo eosin based.
1994
1997
Coryfin, Priovit and Neutrolac were acquired.
Desma Swiss was founded.
1998
1999
Desma Germany was founded. The new production plant in Mede was enaugurated.
Istituto Sieroterapico Berna was acquired and DMS Farmaceutici was founded. Infloran and Flexiban were acquired.
2001
2003
Desma Healthcare and Desma Spain were founded. Rino Calyptol was acquired from Aventis Pharma Spa. The acquisition of Dedrogyl and Sterogyl from Aventis Pharma Spa fostered the European market and gave way to the distribution in Vietnam, Tunisia and Algeria.
Desma France was founded. The acquisition of Akineton from Abbott GmbH & Co. KG opened up new markets in Europe: Austria, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Norway, Holland, Poland, Portugal, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Switzerland
2004
2005
Kalinor was acquired from Abbott Gmbh & Co.KG.
Felison and Ferrofolin were acquired from Bayer Spa.
2009
2011
Control was acquired from Bayer Spa.
Centellase was acquired from Bayer Consumer Care Ag.
2012
2015
SIT provided itself with a network of medical sales reps.
Desma France provided itself with a network of medical sales reps.
2017
2018
Desma Spain has provided itself with a network of medical sales reps.